|
AGPAT5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.797700E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.144500E-03 |
| Normal-vs-Stage2 |
6.166000E-02 |
| Normal-vs-Stage3 |
6.641200E-01 |
| Normal-vs-Stage4 |
1.048810E-01 |
| Stage1-vs-Stage2 |
8.693200E-01 |
| Stage1-vs-Stage3 |
1.119710E-02 |
| Stage1-vs-Stage4 |
9.158000E-01 |
| Stage2-vs-Stage3 |
1.038190E-01 |
| Stage2-vs-Stage4 |
9.629600E-01 |
| Stage3-vs-Stage4 |
1.759960E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.312300E-02 |
| Normal-vs-AfricanAmerican |
8.786200E-02 |
| Normal-vs-Asian |
3.167800E-02 |
| Caucasian-vs-AfricanAmerican |
2.295200E-01 |
| Caucasian-vs-Asian |
1.958200E-01 |
| AfricanAmerican-vs-Asian |
8.628000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.846240E-02 |
| Normal-vs-Female |
1.030070E-02 |
| Male-vs-Female |
6.654600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.222290E-03 |
| Normal-vs-Age(41-60Yrs) |
1.967170E-01 |
| Normal-vs-Age(61-80Yrs) |
6.402200E-02 |
| Normal-vs-Age(81-100Yrs) |
8.710400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.505600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.167600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.360600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.169600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.604400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.519400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.238300E-04 |
| Classical-VS-Follicular |
1.819660E-02 |
| Classical-VS-Other |
8.536400E-01 |
| Classical-VS-Normal |
1.354480E-02 |
| Tall-VS-Follicular |
2.13219999999348E-05 |
| Tall-VS-Other |
1.640050E-01 |
| Tall-VS-Normal |
1.130390E-01 |
| Follicular-VS-Other |
3.855200E-01 |
| Follicular-VS-Normal |
3.241900E-04 |
| Other-VS-Normal |
4.491000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.283700E-03 |
| Normal-vs-N1 |
8.199800E-01 |
| N0-vs-N1 |
5.064100E-02 |
|
|
